Literature DB >> 32002572

A systematic review of the indirect and social costs studies in fragility fractures.

M Ruiz-Adame1, M Correa2.   

Abstract

Fragility fractures (FF) are the main clinical consequence of osteoporosis. FF lead to a loss in quality of life (QL), increased dependency and higher costs due to loss of productivity. Despite this, very few studies have been performed about the indirect or social costs of FF. The objective of this review was to systematically synthesize published evidence regarding indirect costs of FF. We conducted a systematic literature review of empirical studies published as peer review papers between 1998 and 2019. A total of 295 papers were found about costs and osteoporosis. After an iterative process, only 16 papers fit the criteria of selection. Despite the important consequences for QL, only seven studies have included research of the issue and only one about dependency. Treatments are cost-effective, but adherence is low. Multiple fractures, older age and low socioeconomic profile imply higher costs. Most studies are performed using the human capital methodology. The main two variables are loss of productivity and absenteeism. Most of the people included in the samples are out of the active population. Those studies that include a follow-up period vary in a range between 3 months and 2 years. Depending on sample and methodology, the indirect costs (IC) are between 2 and 50%. The direct costs associated with FF generally far outweigh the IC. There is a lack of studies about the effects of treatments and adherence and about the dependency system. The changing role of women in coming generations will increase indirect costs.

Entities:  

Keywords:  Fragility fractures; Indirect costs; Osteoporosis; Social costs

Mesh:

Year:  2020        PMID: 32002572     DOI: 10.1007/s00198-020-05319-x

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  36 in total

Review 1.  Estimating prevalence of osteoporosis: examples from industrialized countries.

Authors:  S W Wade; C Strader; L A Fitzpatrick; M S Anthony; C D O'Malley
Journal:  Arch Osteoporos       Date:  2014-05-16       Impact factor: 2.617

Review 2.  An overview and management of osteoporosis.

Authors:  Tümay Sözen; Lale Özışık; Nursel Çalık Başaran
Journal:  Eur J Rheumatol       Date:  2016-12-30

3.  Fragility fractures and the osteoporosis care gap: an international phenomenon.

Authors:  L Giangregorio; A Papaioannou; A Cranney; N Zytaruk; J D Adachi
Journal:  Semin Arthritis Rheum       Date:  2006-04       Impact factor: 5.532

Review 4.  Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review.

Authors:  V Elliot-Gibson; E R Bogoch; S A Jamal; D E Beaton
Journal:  Osteoporos Int       Date:  2004-07-16       Impact factor: 4.507

5.  Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden.

Authors:  John A Kanis; Olof Johnell; Anders Oden; Frederik Borgstrom; Helena Johansson; Chris De Laet; Bengt Jönsson
Journal:  Osteoporos Int       Date:  2004-04-22       Impact factor: 4.507

Review 6.  Excess mortality following hip fracture: a systematic epidemiological review.

Authors:  B Abrahamsen; T van Staa; R Ariely; M Olson; C Cooper
Journal:  Osteoporos Int       Date:  2009-05-07       Impact factor: 4.507

Review 7.  Diagnosis of osteoporosis and assessment of fracture risk.

Authors:  John A Kanis
Journal:  Lancet       Date:  2002-06-01       Impact factor: 79.321

Review 8.  Major osteoporotic fragility fractures: Risk factor updates and societal impact.

Authors:  Paola Pisani; Maria Daniela Renna; Francesco Conversano; Ernesto Casciaro; Marco Di Paola; Eugenio Quarta; Maurizio Muratore; Sergio Casciaro
Journal:  World J Orthop       Date:  2016-03-18

Review 9.  A systematic review of hip fracture incidence and probability of fracture worldwide.

Authors:  J A Kanis; A Odén; E V McCloskey; H Johansson; D A Wahl; C Cooper
Journal:  Osteoporos Int       Date:  2012-03-15       Impact factor: 4.507

10.  Clinician's Guide to Prevention and Treatment of Osteoporosis.

Authors:  F Cosman; S J de Beur; M S LeBoff; E M Lewiecki; B Tanner; S Randall; R Lindsay
Journal:  Osteoporos Int       Date:  2014-08-15       Impact factor: 4.507

View more
  6 in total

1.  Osteoporosis treatment with risedronate: a population pharmacokinetic model for the description of its absorption and low plasma levels.

Authors:  B Cardozo; E Karatza; V Karalis
Journal:  Osteoporos Int       Date:  2021-05-17       Impact factor: 4.507

Review 2.  The SAFEST review: a mixed methods systematic review of shock-absorbing flooring for fall-related injury prevention.

Authors:  Amy Drahota; Lambert M Felix; James Raftery; Bethany E Keenan; Chantelle C Lachance; Dawn C Mackey; Chris Markham; Andrew C Laing
Journal:  BMC Geriatr       Date:  2022-01-06       Impact factor: 3.921

3.  Characteristics Associated with Acute-Phase Response following First Zoledronic Acid Infusion in Brazilian Population with Osteoporosis.

Authors:  Bruno S A Ferreira; Bernardo M da Cunha; Luciana P Valadares; Larissa A Moreira; Frederico G A Batista; Cristiane da F Hottz; Marina M P Lins; Gabriel G R Magalhães; Luanna M de Arruda; Sergio H R Ramalho
Journal:  J Osteoporos       Date:  2021-12-29

4.  Cortical bone thickness of the distal radius predicts the local bone mineral density.

Authors:  Florian Schmidutz; Christoph Schopf; Shuang G Yan; Marc-Daniel Ahrend; Christoph Ihle; Christoph Sprecher
Journal:  Bone Joint Res       Date:  2021-12       Impact factor: 5.853

5.  Efficacy of Recombinant Human Parathyroid Hormone versus Vertebral Augmentation Procedure on Patients with Acute Osteoporotic Vertebral Compression Fracture.

Authors:  Pengguo Gou; Zhihui Zhao; Chen Yu; Xuefeng Hou; Gang Gao; Ting Zhang; Feng Chang
Journal:  Orthop Surg       Date:  2022-08-26       Impact factor: 2.279

6.  A self-powered implantable and bioresorbable electrostimulation device for biofeedback bone fracture healing.

Authors:  Guang Yao; Lei Kang; Cuicui Li; Sihong Chen; Qian Wang; Junzhe Yang; Yin Long; Jun Li; Kangning Zhao; Weina Xu; Weibo Cai; Yuan Lin; Xudong Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-13       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.